The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease-free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease-free interval or survival.
No takes yet. Share an insight, caveat, or question.
Lipton et al. (1992) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: